Orthopaedic News and Research

RSS

Botox relieves plantar fasciitis pain

Botulinum toxin A may be more effective than steroids for the treatment of plantar fasciitis, research suggests.

25 Jan 2013

UTHealth NRC to sponsor forum on sports-related concussions

Super Bowl-winning lineman turned orthopaedic surgeon Mark Adickes, M.D., is moderating a free public forum to help parents, athletes and trainers spot the warning signs of concussion.

24 Jan 2013

BonAlive Biomaterials, Olympus Biotech sign multi-year exclusive distribution agreement

BonAlive Biomaterials Ltd, a manufacturer of implantable medical devices and an emerging leader in indications involving the treatment of chronically infected bone, and Olympus Biotech International Ltd, a wholly owned company of Olympus Corporation focused on minimally-invasive regenerative therapies in bone and soft tissues, today announced the signing of a multi-year exclusive distribution agreement.

From Evident Corporation - Life Sciences 21 Jan 2013

Ceram to develop its Controlled Release Technology for the delivery of selected AstraZeneca compounds

AstraZeneca, a global pharmaceutical company, has signed an agreement with Ceram Research Ltd, the international materials development company, for Ceram to develop its Inorganic-based Controlled Release Technology in a feasibility study for the delivery of selected AstraZeneca compounds.

18 Jan 2013

The Journal of Bone & Joint Surgery’s new title is BJJ

A new era dawns: 2013 sees The Journal of Bone & Joint Surgery (British Volume), our much trusted and reliable touchstone in orthopaedic literature, change name to 'The Bone & Joint Journal'.

16 Jan 2013

Dizziness does not hamper neck pain therapy

Neck pain patients with dizziness may suffer more pain and disability than their peers without dizziness, but they are no less likely to improve with chiropractic treatment, study findings indicate.

15 Jan 2013

Neurolysis combats hip replacement sciatic nerve pain

Preliminary research suggests that neurolysis can significantly reduce neuropathic pain in patients who develop sciatic nerve palsy after total hip replacement.

14 Jan 2013

FDA clears Soft Tissue Regeneration’s STR GRAFT

Soft Tissue Regeneration, an early stage orthopedic device company that has developed a breakthrough tissue engineering platform used to regenerate ligaments and tendons, announced today that it has received FDA clearance to market its STR GRAFT, a biodegradable scaffold used for soft tissue augmentation and rotator cuff repair.

3 Jan 2013

Bariatric surgery succeeds when new year resolutions to lose weight fail

For years Blanca Ramirez, like many Americans, started each new year with a resolution to lose weight. But no more. "I lost 55 pounds this year and the weight is rolling off and will stay off," said the 42 year-old, married, mother of three. Ramirez underwent bariatric surgery at Loyola Center for Metabolic Surgery & Bariatric Care in August and has lost 55 pounds in four months.

28 Dec 2012

MEDNAX acquires South Oakland Anesthesia Associates

MEDNAX, Inc., today announced the acquisition of South Oakland Anesthesia Associates, P.C., a physician group practice that provides anesthesia care and pain management services at three hospitals, four ambulatory surgery centers, one eye center, and four pain management centers throughout Oakland, Wayne and Macomb counties in Michigan.

21 Dec 2012

No direct link between dental procedures and prosthetic joint infection

The American Academy of Orthopaedic Surgeons (AAOS), and the American Dental Association (ADA) found that there is insufficient evidence to recommend the routine use of antibiotics for patients with orthopaedic implants to prevent infections prior to having dental procedures because there is no direct evidence that routine dental procedures cause prosthetic joint infections.

19 Dec 2012

Arthritis, rheumatism and total joint arthroplasty: an interview with Dr Ravi and Dr Hawker

Arthritis translates to “joint inflammation.” The most common form of arthritis is osteoarthritis (OA), which affects 12-15% of North Americans over the age of 60, and will increase in prevalence as our population ages.

19 Dec 2012

Cedars-Sinai physician-scientist receives grant to study Charcot-Marie-Tooth disease

A Cedars-Sinai physician-scientist has been awarded a $3 million grant from the California Institute for Regenerative Medicine to study with new stem cell technology Charcot-Marie-Tooth disease, the most common inherited neurological disorder and which damages nerves that control muscles.

14 Dec 2012

Cedars-Sinai scientist to study Charcot-Marie-Tooth disease

14 Dec 2012

Max Reinhardt named worldwide President of Depuy Synthes Spine

The DePuy Synthes Companies of Johnson & Johnson announced today that Max Reinhardt has been named Worldwide President of DePuy Synthes Spine, a global leader in spinal care. Mr. Reinhardt has been with the company since 2002, most recently as Vice President of Worldwide Marketing.

13 Dec 2012

Moximed commences KineSpring System clinical trial in knee osteoarthritis

Moximed, Inc. announced today that the KineSpring System, an implantable medical spring that works by unloading the weight on the diseased knee joint, has been successfully implanted in the first patient enrolled in its US clinical study, SOAR.

11 Dec 2012

Gene therapy could represent new treatment option for severe orthopaedic injuries

Gene therapy involving modified stem cells obtained from fatty tissue and bone marrow could represent a new option for the treatment of severe orthopaedic injuries to the extremities.

7 Dec 2012

Galectins play an important role in development of osteoarthrosis

Inflammatory joint disease (arthritis) is affecting more and more, and especially older, people. In a recent survey by Statistik Austria, 39 per cent of people over the age of 60 stated that they have a form of arthritis. One particular form of the condition is osteoarthrosis, which is wear and tear on the joints.

6 Dec 2012

Health care programs a clear target in deficit reduction efforts

As negotiators debate proposals to trim entitlement programs such as Medicare and Medicaid, stakeholders ranging from public hospitals to physician groups lobby to protect their interests.

6 Dec 2012

Hip prosthesis lasts for over 20 years

The Zweymüller prosthesis, developed at the end of the 1970s, was one of the first to be anchored in the bone without using bone cement to fix it in place. The prosthesis's special geometry and surface guarantee its stable anchoring and natural integration into the bone.

3 Dec 2012